Cargando…

Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance

The efficacy of several therapeutic strategies against cancer, including cytotoxic drugs, radiotherapy, targeted immunotherapies and oncolytic viruses, depend on intact type I interferon (IFN) signaling for the promotion of both direct (tumor cell inhibition) and indirect (anti-tumor immune response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budhwani, Megha, Mazzieri, Roberta, Dolcetti, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110817/ https://www.ncbi.nlm.nih.gov/pubmed/30186768 http://dx.doi.org/10.3389/fonc.2018.00322

Ejemplares similares

Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs
por: Waryah, Charlene, et al.
Publicado: (2023)

Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
por: Muraro, Elena, et al.
Publicado: (2022)

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression
por: Escobar, Giulia, et al.
Publicado: (2014)

Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021)

Type I interferon-mediated tumor immunity and its role in immunotherapy
por: Yu, Renren, et al.
Publicado: (2022)

Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack
por: Hamilton, Duane H., et al.
Publicado: (2018)

Harnessing Oncolytic Virus-Mediated Anti-Tumor Immunity
por: Schirrmacher, Volker, et al.
Publicado: (2014)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Harnessing type I interferon-mediated immunity to target malignant brain tumors
por: Lim, Juhee, et al.
Publicado: (2023)

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
por: Cangemi, Michela, et al.
Publicado: (2019)

Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment
por: Allavena, Paola, et al.
Publicado: (2022)

Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
por: Schiavoni, Giovanna, et al.
Publicado: (2013)

Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
por: Zaarour, RF., et al.
Publicado: (2023)

RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers
por: Abraham, Hannah G., et al.
Publicado: (2021)

Editorial: Impact of Cancer Plasticity on Drug Resistance and Treatment in Solid Tumors
por: Cohen, Pascale A., et al.
Publicado: (2020)

Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment
por: Thomas, Graham, et al.
Publicado: (2021)

Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment
por: Rodriguez, Yamila I., et al.
Publicado: (2016)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

Influence of tumors on protective anti-tumor immunity and the effects of irradiation
por: Foulds, Gemma A., et al.
Publicado: (2013)

Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models
por: Moi, Davide, et al.
Publicado: (2023)

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
por: Croft, Priyakshi Kalita-de, et al.
Publicado: (2021)

Metabolic Plasticity in Chemotherapy Resistance
por: Desbats, Maria Andrea, et al.
Publicado: (2020)

Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
por: Baram, Tamir, et al.
Publicado: (2021)

Anti-inflammatory properties of Type I interferons
por: Billiau, Alfons
Publicado: (2006)

Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells
por: Shou, P, et al.
Publicado: (2016)

GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway
por: Mazzieri, Alessio, et al.
Publicado: (2023)

Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling
por: Kirby, Duncan, et al.
Publicado: (2021)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
por: Grard, Marion, et al.
Publicado: (2021)

Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
por: Alves, Eric, et al.
Publicado: (2021)

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies
por: Chan, Anissa S. H., et al.
Publicado: (2022)

Metabolic Plasticity of Tumor Cell Mitochondria
por: Cannino, Giuseppe, et al.
Publicado: (2018)

Type I interferon is selectively required by dendritic cells for immune rejection of tumors
por: Diamond, Mark S., et al.
Publicado: (2011)

Palliative Radiofrequency Ablation Accelerates the Residual Tumor Progression Through Increasing Tumor-Infiltrating MDSCs and Reducing T-Cell-Mediated Anti-Tumor Immune Responses in Animal Model
por: Wu, Hao, et al.
Publicado: (2020)

Type I interferon induces cancer stem cells-mediated chemotherapy resistance
por: De Martino, Mara, et al.
Publicado: (2022)

Pharmacological Modulation of Anti-Tumor Immunity Induced by Oncolytic Viruses
por: Forbes, Nicole E., et al.
Publicado: (2014)

Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment
por: Demaria, Sandra, et al.
Publicado: (2013)

The mechanisms on evasion of anti-tumor immune responses in gastric cancer
por: Wang, Junyang, et al.
Publicado: (2022)

CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity
por: Contreras-Kallens, Pamina, et al.
Publicado: (2022)

Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment
por: Bi, Qing, et al.
Publicado: (2022)

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment
por: Lin, Xiaoping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0s6lv9lo889e9dsk2r9v7v6et1